You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SGLT-2 inhibitor, Chronic heart failure, tissue sodium,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular

Not yet recruiting
  • SGLT2 Inhibitiors Remodeling Effect
  • Chronic Heart Disease
  • Sodium-glucose cotransporter 2 inhibitor
  • (no location specified)
Nov 14, 2023

SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

Recruiting
  • Coronary Artery Disease
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Shah Alam, Selangor, Malaysia
    Institute for Clinical Research, National Institutes of Health,
Nov 9, 2023

SGLT2 Inhibition in Heart Failure

Recruiting
  • Heart Failure
  • Sodium-glucose cotransporter 2 inhibitor
  • Belfast, United Kingdom
    Belfast Health and Social Care Trust
Nov 15, 2023

Type 2 Diabetes Trial (SGLT2 inhibitor)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • SGLT2 inhibitor
  • (no location specified)
Feb 12, 2023

Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Porto, Portugal
  • +3 more
Aug 9, 2023

Heart Failure Trial in Denmark (Digital letter)

Recruiting
  • Heart Failure
  • Digital letter
  • Copenhagen, Denmark
  • +4 more
Jun 5, 2023

Heart Failure, Reduced Ejection Fraction Heart Failure Trial in Damanhur (Empagliflozin 10 MG, Dapagliflozin 10 MG)

Recruiting
  • Heart Failure
  • Reduced Ejection Fraction Heart Failure
  • Empagliflozin 10 MG
  • Dapagliflozin 10 MG
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Oct 3, 2023

Heart Failure Acute, Ventilator Lung Trial in Taipei (SGLT2 inhibitor)

Recruiting
  • Heart Failure Acute
  • Ventilator Lung
  • SGLT2 inhibitor
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 16, 2023

Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan

Recruiting
  • Heart Failure
  • +2 more
  • SGLT2 inhibitor
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCSS
Jun 28, 2023

Diabetes, Heart Failure Trial in Singapore (Dapagliflozin 10 MG [Forxiga])

Completed
  • Diabetes Mellitus
  • Heart Failure
  • Dapagliflozin 10 MG [Forxiga]
  • Singapore, Singapore
    National Heart Centre Singapore
Jan 13, 2023

Heart Failure, Volume Overload Trial in New Haven (Direct Sodium Removal Infusate 2.0)

Recruiting
  • Heart Failure
  • Volume Overload
  • Direct Sodium Removal Infusate 2.0
  • New Haven, Connecticut
    Yale University
Jul 25, 2023

Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • +3 more
  • Dapagliflozin 10mg Tab
  • Placebo
  • Moscow, Russian Federation
    National Medical Research Center for Cardiology, Ministry of Hea
Mar 20, 2023

Heart Failure With Reduced Ejection Fraction Trial in Chicago (SGLT2i, No SGLT2i)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Chicago, Illinois
    University of Chicago
Nov 11, 2022

Heart Failure Trial (Finerenone, Empagliflozin)

Not yet recruiting
  • Heart Failure
  • (no location specified)
Sep 5, 2023

Gliflozins on HF in Regurgitant Rheumatic Heart

Not yet recruiting
  • Rheumatic Heart Disease
  • Heart Failure
  • SGLT2 inhibitor
  • (no location specified)
Oct 27, 2023

Acute Decompensated Heart Failure Trial in Chicago (SGLT2i, No SGLT2i)

Not yet recruiting
  • Acute Decompensated Heart Failure
  • Chicago, Illinois
    University of Chicago
Jun 10, 2022

Acute Decompensated Heart Failure Trial in Grodzisk Mazowiecki (Empagliflozin 10 MG, Dapagliflozin 10 MG, Placebo)

Recruiting
  • Acute Decompensated Heart Failure
  • Empagliflozin 10 MG
  • +2 more
  • Grodzisk Mazowiecki, Poland
    Autonomous Public Specialist Western John Paul II Hospital
Mar 7, 2023

Heart Failure With Reduced Ejection Fraction, Congestion Trial in New York (Ertugliflozin, Placebo)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Congestion
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 29, 2021

Acute Kidney Injury, Kidney Failure, Sodium Glucose Cotransporter-2 Inhibitors Trial in Newtown (SGLT2 inhibitor or matched )

Not yet recruiting
  • Acute Kidney Injury
  • +2 more
  • SGLT2 inhibitor or matched placebo
  • Newtown, New South Wales, Australia
    The George Institute for Global Health
Jul 19, 2022

Chronic Coronary Syndrome, Atrial Fibrillation Trial (Dapagliflozin 10mg Tab, Placebo Tab)

Not yet recruiting
  • Chronic Coronary Syndrome
  • Atrial Fibrillation
  • Dapagliflozin 10mg Tab
  • Placebo Tab
  • (no location specified)
May 9, 2023

Heart Failure, Sleep Disordered Breathing Trial in New York (Dapagliflozin, WatchPat)

Not yet recruiting
  • Heart Failure
  • Sleep Disordered Breathing
  • New York, New York
    Vivian and Seymour Milstein Family Heart Center
Mar 8, 2022

Acute Myocardial Infarction, Heart Failure Trial in Seoul (SGLT2 inhibitor, Control)

Recruiting
  • Acute Myocardial Infarction
  • Heart Failure
  • SGLT2 inhibitor
  • Control
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 11, 2021

Diabetes, Type 2, Endothelial Dysfunction Trial in Boston (Dapagliflozin, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Endothelial Dysfunction
  • Boston, Massachusetts
    BU School of Medicine Evans 748
Jun 1, 2022

Heart Failure Trial (Dapagliflozin, Placebo)

Not yet recruiting
  • Heart Failure
  • (no location specified)
Sep 19, 2022

Type2 Diabetes, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Recruiting
  • Type2 Diabetes
  • Heart Failure With Preserved Ejection Fraction
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
  • +1 more
Jan 21, 2023